DoD Prostate Cancer, Implementation Science Award | HT942524PCRPISA

Opportunity Information: Apply for HT942524PCRPISA

The **DoD Prostate Cancer – Implementation Science Award (FY24 PCRP)** provides funding for studies aimed at accelerating the adoption of **evidence-based interventions, clinical practices, tools, and policies** in **prostate cancer care, prevention, and survivorship**. The focus is on bridging the gap between **research, practice, and policy** to improve patient outcomes, access to care, and healthcare effectiveness.

### **Key Objectives:** - Fund **implementation science** studies that enhance the systematic adoption of proven interventions in **clinical and community settings**. - Prioritize research with **major, near-term impact** that accelerates the integration of best practices. - Target studies benefiting **prostate cancer patients** or **at-risk populations** with a clear **research transition plan** for real-world application. - Promote **multi-level engagement** (patients, providers, communities, healthcare systems).

### **Research Priorities:** Eligible projects may focus on: - **Small-scale clinical trials (up to Phase 2)** with strategies to rapidly translate research into practice. - **Behavioral and lifestyle interventions** targeting patients, providers, communities, or policy makers. - **Comparative effectiveness research** to assess benefits and risks of various treatments. - **Strategies to eliminate barriers** to healthcare access and improve equity. - **Scaling and sustaining** evidence-based interventions and guidelines.

**Preliminary data** demonstrating feasibility and scientific rationale are required, though they don’t need to be exclusive to prostate cancer.

### **Community & Patient Advocacy Involvement:** - Proposals must include **active engagement** with members of **targeted communities** and **prostate cancer consumer advocates** in research design, execution, oversight, and dissemination. - Communication between researchers and the community should be continuous and **bidirectional**. - Advocates can be prostate cancer patients, caregivers, or community representatives with knowledge relevant to the project.

### **Health Equity & Disproportionately Affected Populations:** - Encouragement to address **health disparities** and ensure **equal access** to advances in prostate cancer care.

### **Funding & Collaboration Options:** - **Maximum budget: $2M** in **direct costs** per award. - The **total program budget is $9.6M**, expected to fund **~3 projects**. - Encourages **collaborative applications** with **Partnering Principal Investigators (PIs)** from different scientific/clinical backgrounds. - Applications from **military, VA, and cross-sector collaborations** are highly encouraged.

### **Clinical Trial Considerations:** - **Small-scale clinical trials** (focused on implementation) are eligible, but **correlative studies and preclinical animal research** are **not** in scope. - Trials must have plans for **FDA clearance (if needed) within 60 days of the award**. - Encouraged to leverage the **Prostate Cancer Clinical Trials Consortium (PCCTC)** for rapid trial initiation.

### **Award Timeline & Requirements:** - Applications due in **FY24**, with awards to be made by **September 30, 2025**. - Funds must be used by **September 30, 2030**. - Proposals must align with federal guidelines for **rigorous study design** and **transparent reporting**.

This funding opportunity is designed to **rapidly translate prostate cancer research into practice**, ensuring that patients, especially those in underserved populations, receive timely and effective care.

• The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Prostate Cancer, Implementation Science Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on 2024-05-07.
• Applicants must submit their applications by 2024-08-30. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2025.)
• The number of recipients for this funding is limited to 3 candidate(s).
• Eligible applicants include: Unrestricted.

Apply for HT942524PCRPISA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: